Undocumented with Type 1 Diabetes - A Three-Part Series

We explore the hurdles to type 1 diabetes that undocumented immigrants, and children of undocumented immigrants, face in the United States.

Articles

The pharmacy chain admits to dispensing pens in packs of five, even when the prescribed amount called for less, and then billed the programs for the extra amount.

Five questions with a diabetes health data geek about how data might be harnessed to improve diabetes care now and in the future.

Dr. Sanjeev N. Mehta, a Joslin Diabetes Center pediatric endocrinologist, sees opportunity in standardizing patient data collection. He’s collaborating with the T1D Exchange Quality Improvement Collaborative to harness clinical data to improve diabetes care.

A stark report on insulin costs finds the price of standalone insulins on the market rose from $0.13 a unit to $0.25 a unit during that time.

A young woman with type 1 diabetes shares some tips you might not necessarily get from a certified diabetes educator.

The Eversense CGM available on the U.S. market has a sensor that is only approved for 90 days of use. An 180-day sensor is already available in Europe.

A college student learned that requesting accommodations for blood sugar management was no shortcut to making the grade at a prestigious school.

G. Ford Gilbert attempted to influence Alabama lawmakers to gain insurance coverage for Trina Health’s controversial diabetes treatment clinics.

A three-part examination of the unique challenges undocumented immigrants and U.S. children of undocumented immigrants face to receiving necessary type 1 diabetes care.

The Trump Administration proposes barring immigrants who might use Medicaid and CHIP. Health officials warn this could cause many to forgo routine care. This the final part in our “Undocumented with Type 1 Diabetes” series.